Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simbrinza Phase 3 in Glaucoma/Ocular Hypertension
NCT01297920Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Mar 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of brinzolamide + brimonidine in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Mar 2011; status: completed.
02
Drugs
brinzolamide + brimonidine
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01297920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01297920.